FIELD: medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to an anti-thrombosis, anti-coagulating, fibrin-depolymerizing and fibrinolytic agent for intranasal administration containing semax. The claimed agent possesses high activity and effectiveness as compared with the known agents.
EFFECT: enhanced medicinal properties of agent.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT | 2005 |
|
RU2290194C1 |
| ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
| ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| PEPTIDES WITH ANTICOAGULANT, FIBRINOLYTIC, ANTI-PLATELET AND ANTI-THROMBOSIS ACTIVITY | 2005 |
|
RU2286166C1 |
| PEPTIDE POSSESSING ANTICOAGULANT, FIBRIN-DEPOLYMERIZING, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2289423C1 |
| PEPTIDE POSSESSING ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2288736C1 |
| ANTITHROMBOSIS AGENT | 1997 |
|
RU2138269C1 |
| ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
| APTAMER OLIGONUCLEOTIDE - DIRECT THROMBIN INHIBITOR | 2008 |
|
RU2401306C2 |
